About us
Our mission is to simplify and standardize Spatial Multiomics analysis, making it widely accessible through cutting-edge, AI-powered computational solutions coupled with comprehensive visualization tools.
At Tixomics™, we simplify and standardize spatial multiomics analysis through advanced computational tools. We combine expertise in image analysis, AI, and bioinformatics to help biotech, pharma, and research teams extract meaningful insights from complex tissue data.
Our platform, Celtix™, enables end-to-end analysis of high-plex spatial proteomics and transcriptomics data, from processing to visualization and interpretation. It supports deployment across cloud, desktop, and enterprise environments, giving users full flexibility and control.
Through software and consulting, we deliver practical solutions that accelerate discovery in precision medicine and pathology.
Bassem Ben Cheikh, PhD
Tixomics™ was founded in 2024 by Dr. Bassem Ben Cheikh, CEO, who brings over a decade of experience in biomedical image analysis, bioinformatics, and digital pathology. His work spans artificial intelligence, spatial biology, and the development of tools for multiplex immunofluorescence and high-dimensional single-cell analysis.
Prior to founding Tixomics™, he was a Senior Data Scientist and Technical Group Lead at Akoya Biosciences, where he built and led a team focused on computational solutions for spatial proteomics. His work contributed to image processing pipelines, bioinformatics workflows, and the PhenoCycler™-Fusion platform, in collaboration with leading research, biotech, and pharmaceutical partners.
He founded Tixomics™ to address the need for scalable, practical software for spatial multiomics analysis.
Founder & CEO
Oumeima Laifa, PhD
Scientific Advisory Board
Dr. Oumeima Laifa is an AI and medical expert with more than 13 years of experience at the intersection of artificial intelligence, precision medicine, and spatial biology. She holds a Ph.D. in Artificial Intelligence from Sorbonne University and A*STAR (Paris/Singapore), a Master’s in AI and signal processing, and a medical degree.
Her work spans digital pathology, radiomics, multimodal biomarker analytics, and AI-driven spatial analysis of multiplex immunofluorescence and the tumor microenvironment. She has led research and AI programs at institutions including King’s College London, the Francis Crick Institute, NYU Langone Health, and Gustave Roussy, and has collaborated with organizations such as Owkin and Boehringer Ingelheim.
As a member of Tixomics’ Scientific Advisory Board, Dr. Laifa brings a unique combination of AI expertise, clinical insight, spatial biology experience, and industry perspective to help guide the development and scientific strategy of next-generation spatial multiomics analytics.